| 2005 SEMINARS |
| DATE |
TITLE |
SPEAKER |
01/28/05 |
Analysis of genomic data with protein networks |
Joel Pradines
Millennium Pharmaceuticals
|
02/03/05 |
Mapping the notch signaling network with tandem affinity purification-mass spectrometry |
|
03/07/05 |
Using chromatin structure to map the cis-regulatory genome |
|
03/24/05 |
Network biology: from protein interactions to the metabolic network |
|
04/04/05 |
From epistasis networks to cellular function |
|
06/03/05 |
Detecting soluble protein domains by a combination use of proteomics and bioinformatics |
Dawaei Lin
University of Georgia
|
06/07/05 |
A genomic search for catalytic RNAs |
Kourosh Salehi-Astiani
Massachusetts General Hospital |
08/04/05 |
Cell fate decisions revealed through phosphoproteomics |
|
08/26/05 |
Tracking down those elusive PTMs: wide scale profiling of phosphorylation and O-GlcNAC modification |
Scott Ficarro
Genomics Institute of the Novartis Research Foundation |
09/02/05 |
Computational dissection of large gene-expression dynamics (by correlation method) reveals pathways co-regulation changes by conditional c-myc activation |
|
09/19/05 |
Quantitative phospho-tyrosine proteomic analysis of EGFR, HER2 and HER3 signalling |
Yi Zhang
Massachusetts Institute of Technology |
09/20/05 |
Genome-wide identification of cellular network modulators in human B lymphocytes |
|
10/05/05 |
|
|
10/07/05 |
Inhibition of Ras-induced vulva development in C. elegans requires chromatin remodeling and sumoylation |
Gino Poulin
Wellcome Trust/Cancer Research UK Gurdon Institute |
10/21/05 |
Theory of cancer robustness and its medical implications |
|
| |
High-content screening for genome-wide functional analysis of human kinases in endocytosis |
Eberhard Krausz
Max Planck Institute for Molecular Cell Biology and Genetics |
11/21/05 |
Lessons learned from modeling cellular networks |
|
11/22/05 |
Chemical genomic tools for understanding drug action and gene functions |
Gina Nina Giaver
Stanford Genome Technology Center
|
12/12/05 |
Probing biochemical activities, regulatory pathways and human disease using protein chips |
Michael Synder
Yale University |
